School of Nursing Science, University of Witten/Herdecke, Witten, Germany.
Geriatrics Department, University Hospital Parc de Salut Mar, Barcelona, Spain.
Age Ageing. 2018 Jan 1;47(1):68-74. doi: 10.1093/ageing/afx147.
to evaluate the frequency of potentially inappropriate medication (PIM) prescription among older people with dementia (PwD) from eight countries participating in the European study 'RightTimePlaceCare', and to evaluate factors and adverse outcomes associated with PIM prescription.
survey of 2,004 PwD including a baseline assessment and follow-up after 3 months. Interviewers gathered data on age, sex, prescription of medication, cognitive status, functional status, comorbidity, setting and admission to hospital, fall-related injuries and mortality in the time between baseline and follow-up. The European Union(7)-PIM list was used to evaluate PIM prescription. Multivariate regression analysis was used to investigate factors and adverse outcomes associated with PIM prescription.
overall, 60% of the participants had at least one PIM prescription and 26.4% at least two. The PIM therapeutic subgroups most frequently prescribed were psycholeptics (26% of all PIM prescriptions) and 'drugs for acid-related disorders' (21%). PwD who were 80 years and older, lived in institutional long-term care settings, had higher comorbidity and were more functionally impaired were at higher risk of being prescribed two PIM or more. The prescription of two or more PIM was associated with higher chance of suffering from at least one fall-related injury and at least one episode of hospitalisation in the time between baseline and follow-up.
PIM use among PwD is frequent and is associated with institutional long-term care, age, advanced morbidity and functional impairment. It also appears to be associated with adverse outcomes. Special attention should be paid to psycholeptics and drugs for acid-related disorders.
评估参与欧洲“RightTimePlaceCare”研究的八个国家的老年痴呆症(PwD)患者潜在不适当药物(PIM)处方的频率,并评估与 PIM 处方相关的因素和不良后果。
对 2004 名 PwD 进行调查,包括基线评估和 3 个月后的随访。调查员收集了年龄、性别、药物处方、认知状态、功能状态、合并症、环境和住院、跌倒相关伤害和死亡等数据。使用欧盟(7)-PIM 清单评估 PIM 处方。采用多变量回归分析调查与 PIM 处方相关的因素和不良后果。
总体而言,60%的参与者至少有一种 PIM 处方,26.4%的参与者至少有两种。最常开的 PIM 治疗亚组是精神药物(所有 PIM 处方的 26%)和“酸相关疾病药物”(21%)。80 岁及以上、居住在机构长期护理环境中、合并症更高、功能障碍更严重的 PwD 处方两种或更多 PIM 的风险更高。开两种或更多 PIM 与在基线和随访之间发生至少一次跌倒相关伤害和至少一次住院的几率更高相关。
PwD 中 PIM 的使用很普遍,与机构长期护理、年龄、严重的合并症和功能障碍有关。它似乎也与不良后果有关。应特别注意精神药物和酸相关疾病药物。